Provided by Tiger Fintech (Singapore) Pte. Ltd.

NovoCure

16.56
-0.1300-0.78%
Volume:22.00K
Turnover:362.83K
Market Cap:1.85B
PE:-10.95
High:16.59
Open:16.51
Low:16.37
Close:16.69
Loading ...

NovoCure Appoints New President at Annual Meeting

TIPRANKS
·
07 Jun

Novocure Ltd. Conducted Annual Meeting of Shareholders

Reuters
·
07 Jun

Frank X. Leonard, EVP of Novocure Oncology, Reports Disposal of Common Shares

Reuters
·
05 Jun

Novocure data support pancreatic cancer approval, says Wells Fargo

TIPRANKS
·
03 Jun

Piper Sandler Reaffirms Their Buy Rating on NovoCure (NVCR)

TIPRANKS
·
02 Jun

Positive Outlook for NovoCure Amid Promising PANOVA-3 Trial Results and Anticipated FDA Approval

TIPRANKS
·
02 Jun

Novocure Ltd. Plans to File for Regulatory Approval of TTFields Therapy for Pancreatic Cancer in U.S. and Key International Markets by 2025

Reuters
·
02 Jun

Novocure announces results from Phase 3 PANOVA-3 trial

TIPRANKS
·
02 Jun

Novocure Ltd. Plans Regulatory Filing for TTFields Therapy in Pancreatic Cancer in U.S. by 2025

Reuters
·
31 May

Results From the Phase 3 Panova-3 Trial of Novocure’s Tumor Treating Fields (Ttfields) Therapy for Pancreatic Cancer to Be Presented at 2025 Asco Annual Meeting

THOMSON REUTERS
·
31 May

Novocure Ltd - Panova-3 Trial Meets Primary Endpoint With Significant Improvement in Median Os

THOMSON REUTERS
·
31 May

Novocure Ltd - Ttfields Therapy Improves One-Year Survival Rate to 68.1%

THOMSON REUTERS
·
31 May

Novocure: With Ttfields Therapy, Saw Extension in Duration of Time Before Pain Progressed in Study

THOMSON REUTERS
·
31 May

Novocure: Ttfields Therapy for Pancreatic Cancer Shows Clinically Meaningful, Statistically Significant Improvement in Overall Survival

THOMSON REUTERS
·
31 May

Novocure: to Submit Data to FDA in H2 to Support Premarket Approval for Tumor Treating Fields Therapy

THOMSON REUTERS
·
31 May

BRIEF-Novocure Announces Upcoming Investor Events

Reuters
·
27 May

Novocure Ltd. to Present at Jefferies Global Healthcare Conference

Reuters
·
27 May

Novocure Announces Upcoming Investor Events

THOMSON REUTERS
·
27 May

Analysts Offer Insights on Healthcare Companies: NovoCure (NVCR) and Sarepta Therapeutics (SRPT)

TIPRANKS
·
22 May

The Next Frontier to Treat Cancer: Electricity -- WSJ

Dow Jones
·
16 May